Table 4.
Anti-enzymatic results (IC50 µg/mL).
| Products | Anti-AChE | Anti-BChE | Anti-Alpha Amylase | Anti-Tyrosinase | Anti-Urease | Anti-Lipase |
|---|---|---|---|---|---|---|
| EamCE | 22.46 ± 0.91 a | 28.91 ± 1.08 a | 22.66 ± 0.17 a | 38.04 ± 0.98 a | 23.55 ± 1.04 a | 54.93 ± 0.17 a |
| Galantamine * | 6.27 ± 1.15 b | 34.75 ± 1.99 b | Na | Na | Na | Na |
| Acarbose * | Na | Na | 3650.93 ± 10.70 b | Na | Na | Na |
| Kojic acid * | Na | Na | Na | 25.23 ± 0.78 b | Na | Na |
| Thiourea * | Na | Na | Na | Na | 11.57 ± 0.68 b | Na |
| Orlistat * | Na | Na | Na | Na | Na | 0.061 ± 0.001 b |
* Standard compounds. IC50 is defined as the concentration of 50% inhibition percentage. Na: no activity. IC50 was calculated by linear regression analysis and expressed as mean ± SD (n = 3). The values with both superscripts (a, b) in the same columns are significantly different (p < 0.05).